Complete paraplegia after nelarabine treatment in a T-cell acute lymphoblastic leukemia adult patient

Am J Hematol. 2010 Aug;85(8):608. doi: 10.1002/ajh.21719.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adult
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Arabinonucleosides / administration & dosage
  • Arabinonucleosides / adverse effects*
  • Asparaginase / administration & dosage
  • Bone Marrow Diseases / chemically induced
  • Diagnosis, Differential
  • Doxorubicin / administration & dosage
  • Humans
  • Ischemia / diagnosis
  • Leukemic Infiltration / diagnosis
  • Male
  • Mercaptopurine / administration & dosage
  • Methotrexate / administration & dosage
  • Myelitis, Transverse / chemically induced*
  • Myelitis, Transverse / complications
  • Myelitis, Transverse / diagnosis
  • Paraplegia / etiology*
  • Paresthesia / chemically induced
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Recurrence
  • Salvage Therapy
  • Spinal Cord / blood supply
  • Vincristine / administration & dosage

Substances

  • Adrenal Cortex Hormones
  • Antimetabolites, Antineoplastic
  • Arabinonucleosides
  • Vincristine
  • nelarabine
  • Doxorubicin
  • Mercaptopurine
  • Asparaginase
  • Methotrexate